De M. Hungria
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Criteria for referring pediatric and adult patients with hematological diseases to palliative care: Consensus of the Brazilian Association of Hematology, hemotherapy and cell therapy (2025).
Journal: Hematology, transfusion and cell therapy
Published: March 02, 2026
Bispecific Antibody Therapy for Multiple Myeloma: A Practical Toolkit.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 14, 2025
Practical Guidance on the Clinical Management of Ocular Adverse Events Associated with Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma: Latin American Expert Panel Recommendations.
Journal: Oncology and therapy
Published: April 24, 2025
Real-world data on the use of subcutaneous daratumumab plus bortezomib, thalidomide, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma.
Journal: Annals of hematology
Published: January 28, 2025
Expert Opinion on Multiple Myeloma Treatment in Brazil in the Bispecific Antibody Era.
Journal: Clinical lymphoma, myeloma & leukemia
Published: August 22, 2024
The Brazilian association of hematology, hemotherapy, and cell therapy (ABHH) and its absolute commitment to ethics and absence of conflicts of interest.
Journal: Hematology, transfusion and cell therapy
Published: May 31, 2024
Brazilian Real-Life Experience of Multiple Myeloma (MMyBRAve): Improvement in Outcomes, But Remaining Diagnostic and Therapeutic Gaps.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 17, 2024
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.
Journal: Hematology, transfusion and cell therapy
Published: June 17, 2022
Impact of the lactate dehydrogenase in association with the International Staging System prognostic score in multiple myeloma patients treated in real life.
Journal: Hematology, transfusion and cell therapy
Published: March 14, 2022
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients.
Journal: Hematology, transfusion and cell therapy
Published: August 24, 2021
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis.
Journal: Advances in therapy
Published: August 10, 2020
Up-front autologous hematopoietic stem cell transplantation (AHSCT) from a single Brazilian center.
Journal: Bone marrow transplantation
Published: May 10, 2019
Last Updated: 09/26/2026